Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation. / Borovikov, Yurii S. ; Simonyan, Armen O. ; Avrova, Stanislava V. ; Sirenko, Vladimir V.; Redwood, Charles S.; Karpicheva, Olga E.
в: International Journal of Molecular Sciences, Том 21, № 12, 4421, 22.06.2020, стр. 1-17.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation
AU - Borovikov, Yurii S.
AU - Simonyan, Armen O.
AU - Avrova, Stanislava V.
AU - Sirenko, Vladimir V.
AU - Redwood, Charles S.
AU - Karpicheva, Olga E.
N1 - Publisher Copyright: © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/6/22
Y1 - 2020/6/22
N2 - Substitution of Ala for Glu residue in position 173 of γ-tropomyosin (Tpm3.12) is associatedwith muscle weakness. Here we observe that this mutation increases myofilament Ca2+-sensitivityand inhibits in vitro actin-activated ATPase activity of myosin subfragment-1 at high Ca2+. In orderto determine the critical conformational changes in myosin, actin and tropomyosin caused by themutation, we used the technique of polarized fluorimetry. It was found that this mutation changesthe spatial arrangement of actin monomers and myosin heads, and the position of the mutanttropomyosin on the thin filaments in muscle fibres at various mimicked stages of the ATPase cycle.At low Ca2+ the E173A mutant tropomyosin shifts towards the inner domains of actin at all stages ofthe cycle, and this is accompanied by an increase in the number of switched-on actin monomers andmyosin heads strongly bound to F-actin even at relaxation. Contrarily, at high Ca2+ the amount of thestrongly bound myosin heads slightly decreases. These changes in the balance of the strongly boundmyosin heads in the ATPase cycle may underlie the occurrence of muscle weakness. W7, an inhibitorof troponin Ca2+-sensitivity, restores the increase in the number of myosin heads strongly bound toF-actin at high Ca2+ and stops their strong binding at relaxation, suggesting the possibility of usingCa2+-desensitizers to reduce the damaging effect of the E173A mutation on muscle fibre contractility.
AB - Substitution of Ala for Glu residue in position 173 of γ-tropomyosin (Tpm3.12) is associatedwith muscle weakness. Here we observe that this mutation increases myofilament Ca2+-sensitivityand inhibits in vitro actin-activated ATPase activity of myosin subfragment-1 at high Ca2+. In orderto determine the critical conformational changes in myosin, actin and tropomyosin caused by themutation, we used the technique of polarized fluorimetry. It was found that this mutation changesthe spatial arrangement of actin monomers and myosin heads, and the position of the mutanttropomyosin on the thin filaments in muscle fibres at various mimicked stages of the ATPase cycle.At low Ca2+ the E173A mutant tropomyosin shifts towards the inner domains of actin at all stages ofthe cycle, and this is accompanied by an increase in the number of switched-on actin monomers andmyosin heads strongly bound to F-actin even at relaxation. Contrarily, at high Ca2+ the amount of thestrongly bound myosin heads slightly decreases. These changes in the balance of the strongly boundmyosin heads in the ATPase cycle may underlie the occurrence of muscle weakness. W7, an inhibitorof troponin Ca2+-sensitivity, restores the increase in the number of myosin heads strongly bound toF-actin at high Ca2+ and stops their strong binding at relaxation, suggesting the possibility of usingCa2+-desensitizers to reduce the damaging effect of the E173A mutation on muscle fibre contractility.
KW - TROPOMYOSIN
KW - mutations in tropomyosin
KW - muscle weakness
KW - congenital myopathy
KW - Ca2+-sensitivity of myofilament
KW - ATPase activity of myosin
KW - troponin inhibitor W7
KW - Tropomyosin
KW - Congenital myopathy
KW - Mutations in tropomyosin
KW - Troponin inhibitor W7
KW - Muscle weakness
KW - Ca -sensitivity of myofilament
UR - https://www.mdpi.com/1422-0067/21/12/4421
UR - http://www.scopus.com/inward/record.url?scp=85087098258&partnerID=8YFLogxK
U2 - 10.3390/ijms21124421
DO - 10.3390/ijms21124421
M3 - Article
VL - 21
SP - 1
EP - 17
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1422-0067
IS - 12
M1 - 4421
ER -
ID: 60045129